Abstract
Background
Endothelial dysfunction is associated with elevated cardiovascular risk in patients with end-stage renal disease (ESRD). Kidney transplantation has demonstrated significant ability in reducing mortality and improving quality of life in recipients. Recent studies have also reported improvements in endothelial function following kidney transplantation; however, current literature is limited.
Methods
We performed a systematic review of PubMed/Medline, Web of Science, Scopus, Cochrane Library, and CINAHL databases for prospective cohort studies that assessed endothelial function prior to and following kidney transplantation via various clinical markers. Follow-up duration ranged from 1 month to 1 year. A meta-analysis of pooled data was conducted using random-effect models for four key markers: brachial artery flow-mediated dilatation (FMD), high-sensitivity C-reactive protein (hsCRP), nitroglycerin-mediated dilation (NMD), and adiponectin.
Results
We included nine studies in our final analysis with a total of 524 patients. Significant improvement of all four biomarkers was observed after transplantation. The mean difference was 2.81% (95% CI 1.92–3.71, p < 0.00001) for FMD, 17.27 mg/L (95% CI 5.82–28.72, p = 0.003) for hsCRP, 1.05%, (95% CI 0.56–1.54, p < 0.0001) for NMD, and 9.27 µg/mL (95% CI 5.96–12.57, p < 0.00001) for adiponectin.
Conclusion
There is an immediate reversal of endothelial dysfunction in ESRD patients who undergo kidney transplantation, which may explain observed improvements in cardiovascular morbidity in transplant recipients. Future longitudinal studies are needed to understand possible re-emergence of endothelial dysfunction in the long-term postoperative period.
Similar content being viewed by others
References
Augustine J (2018) Kidney transplant: New opportunities and challenges. Cleve Clin J Med 85(2):138–144
Hauk L (2018) Kidney transplantation. Aorn j 107(5):P11–P13
Tonelli M, Wiebe N, Knoll G, Bello A, Browne S, Jadhav D et al (2011) Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transpl 11(10):2093–2109
Cardinal H, Dieudé M, Hébert MJ (2018) Endothelial dysfunction in kidney transplantation. Front Immunol 9:1130
Cerqueira A, Quelhas-Santos J, Sampaio S, Ferreira I, Relvas M, Marques N, et al. Endothelial Dysfunction is associated with cerebrovascular events in pre-dialysis ckd patients: a prospective study. life (Basel). 2021;11(2).
Grandl G, Wolfrum C (2018) Hemostasis, endothelial stress, inflammation, and the metabolic syndrome. Semin Immunopathol 40(2):215–224
Konukoglu D, Uzun H (2017) Endothelial dysfunction and hypertension. Adv Exp Med Biol 956:511–540
Matsuzawa Y, Lerman A (2014) Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment. Coron Artery Dis 25(8):713–724
Narayan J, Das HS, Nath P, Singh A, Mishra D, Padhi PK et al (2020) Endothelial dysfunction, a marker of atherosclerosis, is independent of metabolic syndrome in NAFLD patients. Int J Hepatol 2020:1825142
Cyr AR, Huckaby LV, Shiva SS, Zuckerbraun BS (2020) Nitric oxide and endothelial dysfunction. Crit Care Clin 36(2):307–321
Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115(10):1285–1295
Münzel T (2008) Endothelial dysfunction: pathophysiology, diagnosis and prognosis. Dtsch Med Wochenschr 133(47):2465–2470
Kensinger C, Bian A, Fairchild M, Chen G, Lipworth L, Ikizler TA et al (2016) Long term evolution of endothelial function during kidney transplantation. BMC Nephrol 17(1):160
Jourde-Chiche N, Fakhouri F, Dou L, Bellien J, Burtey S, Frimat M et al (2019) Endothelium structure and function in kidney health and disease. Nat Rev Nephrol 15(2):87–108
Cottone S, Palermo A, Vaccaro F, Mulè G, Guarneri M, Arsena R et al (2007) Inflammation and endothelial activation are linked to renal function in long-term kidney transplantation. Transpl Int 20(1):82–87
McDonough PG (2003) Quorum guidelines for meta-analyses. Fertil Steril 80(1):228
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535
Brooke BS, Schwartz TA, Pawlik TM (2021) MOOSE reporting guidelines for meta-analyses of observational studies. JAMA Surg 156(8):787–788
Peterson J, Welch V, Losos M, Tugwell P (2011) The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute, Ottawa, pp 1–12
Higgins JPT (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC medical research methodology. 2014;14(1):135-.
DerSimonian R, Kacker R (2006) Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28(2):105–114
Caglar K, Yilmaz MI, Vural A, Yenicesu M, Saglam M, Cakir E et al (2007) Endothelial dysfunction and fetuin A levels before and after kidney transplantation. Transplantation 83(4):392–397
Yilmaz MI, Saglam M, Caglar K, Cakir E, Ozgurtas T, Sonmez A et al (2005) Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation. Transplantation 80(12):1660–1666
Sharma J, Kapoor A, Muthu R, Prasad N, Sinha A, Khanna R et al (2014) Assessment of endothelial dysfunction in Asian Indian patients with chronic kidney disease and changes following renal transplantation. Clin Transpl 28(8):889–896
Yilmaz MI, Saglam M, Carrero JJ, Qureshi AR, Caglar K, Eyileten T, et al. Normalization of endothelial dysfunction following renal transplantation is accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of endothelial damage? Clinical transplantation. 2009;23(2):241–8.
Oflaz H, Turkmen A, Turgut F, Pamukcu B, Umman S, Ucar A et al (2006) Changes in endothelial function before and after renal transplantation*. Transpl Int 19(4):333–337
Idorn T, Hornum M, Bjerre M, Jørgensen KA, Nielsen FT, Hansen JM et al (2012) Plasma adiponectin before and after kidney transplantation. Transpl Int 25(11):1194–1203
Chudek J, Adamczak M, Karkoszka H, Budziński G, Ignacy W, Funahashi T et al (2003) Plasma adiponectin concentration before and after successful kidney transplantation. Transpl Proc 35(6):2186–2189
Yilmaz MI, Sonmez A, Saglam M, Yaman H, Unal HU, Gok M et al (2013) Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function. Eur J Clin Invest 43(12):1250–1257
Serwin N, Adamiak D, Wiśniewska M, Marchelek-Myśliwiec M, Serwin K, Cecerska-Heryć E, et al. Adiponectin is unrelated to kidney function or injury markers in renal transplant recipients: A one-year follow-up study. Prostaglandins & other lipid mediators. 2022;159:106618-.
Sharma J, Kapoor A, Muthu R, Prasad N, Sinha A, Khanna R et al (2014) Assessment of endothelial dysfunction in Asian Indian patients with chronic kidney disease and changes following renal transplantation. Clin Transplant 28(8):889–896
Covic A, Goldsmith DJA, Gusbeth-Tatomir P, Buhaescu I, Covic M (2003) Successful renal transplantation decreases aortic stiffness and increases vascular reactivity in dialysis patients. Transplantation 76(11):1573–1577
Schwaiger JP, Lamina C, Neyer U, König P, Kathrein H, Sturm W et al (2006) Carotid plaques and their predictive value for cardiovascular disease and all-cause mortality in hemodialysis patients considering renal transplantation: a decade follow-up. Am J Kidney Dis 47(5):888–897
Bakri RS, Afzali B, Covic A, Sriskantharan R, Bharma-Ariza P, Park W-H et al (2004) Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation. Clin Transpl 18(2):201–204
Abedini S, Holme I, März W, Weihrauch G, Fellström B, Jardine A et al (2009) Inflammation in Renal Transplantation. Clin J Am Soc Nephrol 4(7):1246–1254
Junarta J, Hojs N, Ramphul R, Lowe-Jones R, Kaski JC, Banerjee D. Progression of endothelial dysfunction, atherosclerosis, and arterial stiffness in stable kidney transplant patients: a pilot study. BMC Cardiovascular Disorders. 2020;20(1).
Di Lullo L, House A, Gorini A, Santoboni A, Russo D, Ronco C (2015) Chronic kidney disease and cardiovascular complications. Heart Fail Rev 20(3):259–272
Recio-Mayoral A, Banerjee D, Streather C, Kaski JC (2011) Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease – a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis 216(2):446–451
Awan A, Ahmed, Niu J, Pan S, Jenny, Erickson F, Kevin, Mandayam S, Winkelmayer C, Wolfgang, et al. Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996–2014). American Journal of Nephrology. 2018;48(6):472–81.
Amabile N, Guérin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J et al (2005) Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 16(11):3381–3388
Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y et al (2006) Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 4(3):566–573
Kocak H, Ceken K, Yavuz A, Yucel S, Gurkan A, Erdogan O et al (2006) Effect of renal transplantation on endothelial function in haemodialysis patients. Nephrol Dial Transpl 21(1):203–207
Qamri Z, Pelletier R, Foster J, Kumar S, Momani H, Ware K et al (2014) Early posttransplant changes in circulating endothelial microparticles in patients with kidney transplantation. Transpl Immunol 31(2):60–64
Acknowledgements
None
Funding
This study was not funded by any grant.
Author information
Authors and Affiliations
Contributions
Contributed substantially to the conception or design of the work: MK, SC, CU, AC. Contributed substantially to acquisition, analysis, or interpretation of data: CU, AC, MK. Drafted the manuscript: SC, MS, CT. Revision of the manuscript for important intellectual content: MK, AC, CU, AC, CT, SC.
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Ethical approval
No need.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kanbay, M., Ureche, C., Copur, S. et al. Kidney transplantation: is it a solution to endothelial dysfunction?. Int Urol Nephrol 55, 1183–1191 (2023). https://doi.org/10.1007/s11255-022-03415-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-022-03415-x